Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase

Journal of Cellular Physiology

Volumn 172, Issue 2, 1997, Pages 137-145

  Rabbani, Shafaat A ^a   Gladu, Julienne ^a   Mazar, Andrew P ^b,c   Henkin, Jack ^b   Goltzman, David ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b ABBOTT LABORATORIES   (United States)

^c Angstrom Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE;

AMINO TERMINAL SEQUENCE; ARTICLE; BONE GROWTH; EARLY RESPONSE GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; ONCOGENE C FOS; ONCOGENE C JUN; ONCOGENE C MYC; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTO ONCOGENE; SIGNAL TRANSDUCTION;

ANIMALS; CATTLE; DRUG STABILITY; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GENES, FOS; GENES, JUN; GENES, MYC; HUMANS; OSTEOBLASTS; PEPTIDE FRAGMENTS; PLASMINOGEN ACTIVATORS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-FOS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030855023     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199708)172:2<137::AID-JCP1>3.0.CO;2-P     Document Type: Article

References (55)

1. Achbarou, A., Kaiser, S., Tremblay, G., Ste-Marie, L.-G., Brodt, P., Goltzman, D., and Rabbani, S.A. (1994) Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res., 54:2372-2377.
2. Apella, E., Robinson, E.A., Ullrich, S.J., Stoppelli, M.P., Corti, A., Cassani, G., and Blasi, F. (1987) The receptor binding sequence or urokinase: A biological function for the growth-factor module of proteases. J. Biol. Chem., 262:4437-4440.
3. Beers, W.H., Strickland, S., and Reich, E. (1975) Ovarian plasminogen activator relationship to ovulation and hormonal regulation. Cell, 6:387-394.
4. Behrendt, N., Ploug, M., Patthy, L., Houen, G., Blasi, F., and Dano, K. (1991) The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J. Biol. Chem., 266:7842-7847.
5. Blasi, R. (1993) Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness. BioEssays, 15:105-111.
6. 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J. Exp. Med., 181:1381-1390.
7. Boyd, D., Florent, G., Kim, P., and Brattain, M. (1988) Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines. Cancer Res., 48:3112-3116.
8. Brown, D. (1993) The tyrosine kinase connection: How GPI-anchored proteins activate T cells. Curr. Opin. Immunol., 5:349-354.
9. Callen, D., and Lijnen, H.R. (1991) Basic and clinical aspects of fibrinolysis and thrombolysis. Blood, 78:3114-3124.
10. Candeliere, G.A., Prud'homme, J., and St-Arnaud, R. (1991) Differential stimulation of fos and jun family members by calcitriol in osteoblastic cells. Mol. Endocrinol., 5:1780-1788.
11. Carmeliet, P., Schoonjans, L., Kleckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., van den Oord, J.J., Collen, D., and Mulligan, R.C. (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature, 368:419-424.
12. Casey, P.J. (1995) Protein lipidation in cell signaling. Science, 268:221-225.
13. Cesare, D., Vallone, D., Caracciolo, A., Sassone-Corsi, P., Nerlov, C., and Verde, P. (1995) Heterodimerization of c-Jun with ATF-s and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene, 11:365-376.
14. Chomczynski, P., and Sacchi, N. (1988) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-choloroform extraction. Anal. Biochem., 162:156-159.
15. Danielson, P.E., Rorss-Petter, S., Bow, M.A., Calaretta, L., Douglass, J., Milner, R.J., and Sutcliffe, J.G. (1988) A cDNA clone of the rat mRNA encoding cyclophilin. DNA Cell Biol., 7:261-267.
16. Dano, K., Behrendt, N., Brünner, N. (1994) The urokinase receptor, protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis, 8:189-203.
17. Dano, K., Andreasen, P.A., Grondahl-hansen, J., Kristenson, P., Nielsen, L.S., and Skriver, L. (1985) Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res., 44:139-266.
18. Dewerchin, M., Nuffelen, A.V., Wallays, G., Bouche, A., Moons, L., Carmeliet, M., Mulligan, R.C., and Collen, D. (1996) Generation and characterization of urokinase receptor deficient mice. J. Clin. Invest., 97:870-878.
19. Dony, C., and Gruss, P. (1987) Proto-oncogene c-fos expression in growth regions of fetal bone and mesodermal web tissue. Nature, 328:711-714.
20. Dumler, I., Petri, T., and Schleuning, W.-D. (1994) Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells. FEBS Lett., 343:103-106.
21. Feinberg, A.P., and Vogelstein, B. (1984) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 137:266-267.
22. Fibbi, G., Ziche, M., Morbidelli, L., Magnelli, L., and Del Rosso, M. (1988) Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells. Exp. Cell Res., 179:385-395.
23. Glisin, V., Crkvenjakov, R., and Byus, C. (1974) Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry, 13:2633-2637.
24. Hearing, V.J., Law, L.W., Corti, A., Appella, E., and Blasi, F. (1988) Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. Cancer Res., 48:1270-1278.
25. Higazi, A.A-R., Mazar, A., Wang, J., Reilly, R., Henkin, J., Kniss, D., and Cines, D. (1996) Single-chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1. Blood, 87:3545-3549.
26. Hollas, W., Blasi, F., and Boyd, D. (1991) Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res., 51:3690-3695.
27. Kanse, S.M., Kost, C., Wilhelm, O.G., Andreasen, P.A., and Preissner, K.T. (1996) The urokinase receptor is a major vitronectin binding protein on endothelial cells. Exp. Cell. Res., 224:344-353.
28. Kouzarides, T., and Ziff, E. (1988) The role of the leucine zipper in the fos-jun interaction. Nature, 336:646-651.
29. Kristensen, P., Eriksen, J., Blasi, R., and Dano, K. (1991) Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract. J. Cell Biol., 115:1763-1771.
30. Lee, J.S., Favre, B., Hemmings, B.A., Kiefer, B., and Nagamine, Y. (1993) Okadaic acid-dependent induction of the urokinase-type plasminogen activator gene associated with stabilization and autoregulation of c-Jun. J. Biol. Chem., 269: 2887-2894.
31. Liu, B., Goltzman, D., and Rabbani, S.A. (1993) Regulation of parathyroid hormone related peptide production in vitro by the rat hypercalcemic Leydig cell tumor H-500. Endocrinology, 132:1658-1664.
32. Liu, D.F., and Rabbani, S.A. (1995) Induction of urinary plasminogen activator by retinoic acid results in increased invasiveness of human prostate cancer cells PC-3. Prostate, 27:269-276.
33. Marcotte, P.A., Kozan, I.M., Dorwin, S.A., and Ryan, J.M. (1992) The matrix metalloproteinase pump-1 catalyzes formation of low molecular weight (pro) urokinase in cultures of normal human kidney cells. J. Biol. Chem., 267:13803-13806.
34. Mars, W.M., Kim, T-H., Stolz, D.B., Liu, M-L., and Michalopoulos, G.K. (1996) Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor. Cancer Res., 56:2837-2843.
35. Mazar, A.P., Buko, A., Petros, A.M., Barnathan, E.S., and Henkin, J. (1992) Domain analysis or urokinase plasminogen activator (u-PA): Preparation and characterization of intact A-chain molecules. Fibrinolysis, 6:49-55.
36. Merriman, H.L., La Tour, D., Linkhard, T.A., Mohan, S., Baylink, D.J., and Strong, D.D. (1990) Insulin-like growth factor-I and insulin-like growth factor-II induce c-fos in mouse osteoblastic cells. Calcif. Tissue Int., 46:258-262.
37. Naldini, L., Tamagnone, L., Vigna, E., Sachs, M., Hartmann, G., Birchmeier, W., Daikuhara, Y., Tsubouchi, H., Blasi, F., and Comoglio, P.M. (1992) Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J., 11:4825-4833.
38. Odekon, L.E., Blasi, F., and Rifkin, D. (1994) Requirement for receptor-bound urokinase in plasmin dependent cellular conversion of latent TGF-β to TGF-β. J. Cell. Physiol., 158:398-407.
39. Okazaki, R., Ikeda, K., Sakamoto, A., Nakano, T., Morimoto, K., Kikuchi, T., Urakawa, K., Ogata, E., and Matsumoto, T. (1992) Transcriptional activation of c-fos and c-jun protooncogenes by serum growth factors in osteoblast-like MC3T3-E1 cells. J.B.M.R., 7:1149-1155.
40. Ossowski, L. (1988) In vivo invasion of modified chorioallantoic membrane by tumor cells: The role of cell-surface bound urokinase. J. Cell Biol., 107:2437-2445.
41. Pennica, D., Holmes, W.E., Kohr, W.J., Harkins, R.N., Vehar, G.A., Ward, C.A., Bennett, W.F., Yelverton, E., Seeburg, P.H., Heyneker, H.L., Goeddel, D.V., and Collen, D. (1983) Cloning and expression of human tissue-type plasminogen activator cDNA in E. Coli. Nature, 301:214-221.
42. Ploug, M., Ronne, E., Behrendt, N., Jensen, A.L., Blasi, F., and Dano, K. (1991) Cellular receptor for urokinase plasminogen activator: Carboxy terminal processing and membrane anchoring. J. Biol. Chem., 266:1926-1933.
43. Rabbani, S.A., Desjardins, J., Bell, A.W., Banville, D., Mazar, A., Henkin, J., and Goltzman, D. (1990) An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells. Biochem. Biophys. Res. Commun., 173:1058-1064.
44. Rabbani, S.A., Mazar, A.P., Bernier, S.M., Haw, M., Bolivar, I., Henkin, J., and Goltzman, D. (1992) Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J. Biol. Chem., 267:14151-14156.
45. Rabbani, S.A., Rajwans, N., Achbarou, A. Murthy, K.K., and Goltzman, D. (1994) Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts. FEBS. Lett., 338:69-74.
46. Resh, M.D. (1994) Myristylation and palmitylation of Src family members: The fats of the matter. Cell, 76:411-413.
47. Roldan, A.L., Cubellis, M.V., and Masucci, M.T. (1990) Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO. J., 9:467-474.
48. Ruther, U., Garber, C., Komitowski, D., Muller, R., and Wagner, E.F. (1987) Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature, 325:412-416.
49. Ryder, K., and Nathans, D. (1988) Induction of protooncogene c-jun by serum growth factors. Proc. Natl. Acad. Sci. USA, 85:8464-8467.
50. Ryseck, R.P., Kovary, K., and Bravo, R. (1990) Integrity of fos B leucine zipper is essential for its interaction with jun proteins. Oncogenesis, 5:1091-1093.
51. Shenoy-Scaria, A.M., Gauen, L.K., Kwong, J., Shaw, A.S., and Lublin, D.M. (1993) Palmitylation of an amino-terminal cysteine motif of protein tyrosine kinases p561ck and p59fyn mediates interaction with glycosyl-phosphatidylinositol-anchored proteins. Mol. Cell. Biol., 13:6385-6392.
52. 1 gene results in multifocal inflammatory disease. Nature, 359:693-699
53. Stahl, A., and Mueller, B.M. (1995) The urokinase plasminogen activator receptor, a GPI-linked protein, is localized in caveolae. J. Cell. Biol., 129:335-344.
54. Waltz, D.A., and Chapman, H.A. (1994) Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem., 269:14746-14750.
55. Wei, Y., Lukashev, M., Simon, D.I., Bodary, S.C., Rosenberg, S., Doyle, M.V., and Chapman, H.A. (1996) Regulation of integrin function by the urokinase receptor. Science, 273:1551-1555.